user Sign In

QYResearch Account

Manage your Account and Access Personalized Content.

Sign in

Create Account with us

Manage your Account and Access Personalized Content.

Sign Up
       
  
×

Global Arthritis Drug Market Report, Forecast to 2025

Published Date: 2019-02-10   |   Pages: 90   |   Tables: 103   | Report Id: 986562   | Hits: 10 |   Pharma & Healthcare



Arthritis is condition that causes pain and inflammation in joints. Around 100 different types of arthritis related conditions present globally and it is one of the leading cause of disability worldwide. The most common types of arthritis includes: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, are among others.

Growing burden of incidence of osteoarthritis, psoriatic arthritis and rheumatoid arthritis patients are major factors driving the growth of global arthritis drugs market. According to CDC estimation from 2010-2012, about 52.5 million US adults had some form of arthritis conditions among them persons with age 65 or older reported higher prevalence of arthritis conditions than the other ages due to “wear and tear” on the joints. However, due to lack of proper medication to cure arthritis and higher cost of the medications are hindering the growth of this market over the forecast period.

The global Arthritis Drug market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Arthritis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Arthritis Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

Novartis

Eli Lilly

Celltrion

F. Hoffmann-La Roche

Pfizer

Johnson & Johnson

GSK

...

Segment by Regions

North America

Europe

China

Japan

Segment by Type

Synthetic DMARDs

Biological DMARDs

NSAIDs

Corticosteroids

Analgesics

Segment by Application

Retail Pharmacies

Hospital Pharmacies

Drug Stores

E-Commerce

Licenses Type

Only one user can access the report
Multiple users can access the report

Why QYR

 Fastest report delivery service
 More than 10 years of vast experience
 Operational for 24 * 7 & 365 days
 In-depth and comprehensive analysis
 Excellent after sales support
 Owns large database

Need Help ?

QYR Clients

More Clients...